In recent decades artificial intelligence and machine learning have played a significant role in increasing the efficiency of processes across a wide spectrum of industries. When it comes to the pharmaceutical and biotechnology sectors numerous tools enabled by advancement of computer science have been developed and are now routinely utilized. However there are many aspects of the drug discovery process which can further benefit from refinement of computational methods and tools as well as improvement of accessibility of these new technologies. In this review examples of recent developments in machine learning application are described which have the potential to impact different parts of the drug discovery and development flow scheme. Notably new deep learning-based approaches across compound design and synthesis prediction of binding activity and ADMET properties as well as applications of genetic algorithms are highlighted. Recent applications of machine learning in medicinal chemistry.